{"id":610199,"date":"2022-08-01T13:46:02","date_gmt":"2022-08-01T13:46:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=610199"},"modified":"2022-08-01T13:46:02","modified_gmt":"2022-08-01T13:46:02","slug":"3d-ultrasound-market-size-to-growth-usd-576-billion-by-2030-hitachi-ltd-hologic-bpl-medical-technologies-etc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/3d-ultrasound-market-size-to-growth-usd-576-billion-by-2030-hitachi-ltd-hologic-bpl-medical-technologies-etc_610199.html","title":{"rendered":"3D Ultrasound Market Size to Growth USD 5.76 Billion by 2030 | Hitachi, Ltd, Hologic, BPL Medical Technologies, etc"},"content":{"rendered":"
\n
\"3D<\/a><\/div>\n
\n
3D Ultrasound Market | Emergen Research<\/div>\n<\/div>\n<\/div>\n
Rapid technological advancements made in 3D imaging and rapidly shifting preference for Minimally Invasive Procedures (MIP) are driving market revenue growth<\/div>\n

The global 3D Ultrasound Market<\/a> size was USD 3.28 Billion in 2021 and register a revenue CAGR of 6.5% over the forecast period, according to the latest analysis by Emergen Research. Rapid technological advancements made in 3D imaging and increasing shifting preference for Minimally Invasive Procedures (MIPs) are key factors driving global 3D ultrasound market revenue growth.<\/p>\n

Various pain conditions, such as muscle, joint, ligament, and tendon pain, can be assessed and treated with ultrasound technology. Pain relief injections can even be given without ultrasound imaging, hence these are unlikely to be as efficient and accurate as ultrasound-guided ones, because they are likely to miss the desired target area without aid of imaging equipment. Advancements in ultrasound technology contributing towards cheaper, smaller, and more portable devices provide high-quality imaging, while applications of ultrasound machines have become much more widespread and extended to many healthcare fields including pain management. Primary care physicians, orthopedists, rheumatologists, and sports medicine doctors, among others, now rely on ultrasound as a vital diagnostic and therapeutic tool in the field of pain management. Additionally, rapidly shifting preference for Minimally Invasive Procedures (MIP) and increasing usage of ultrasound in pain management are driving market revenue growth to a greater extent.<\/p>\n

Get a sample of the report @ https:\/\/www.emergenresearch.com\/request-sample\/1240<\/a><\/strong><\/p>\n

Some major companies in the market report include <\/strong><\/p>\n

GE Healthcare (a division of General Electric Company), Philips Healthcare (a division of Koninklijke Philips N.V.), Canon Medical Systems Corporation, Hitachi, Ltd., Siemens Healthcare GmbH, Chison Medical Technologies Co., Ltd., Samsung Medison Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., and BPL Medical Technologies.<\/p>\n

 <\/p>\n

\"\"<\/p>\n

 <\/p>\n

Rapid technological advancements made in 3D imaging is further contributing to market revenue growth substantially. In recent times, numerous ultrasound equipment use AI in a certain capacity, for instance, Philips’ Epiq system uses anatomical intelligence. AI can automatically segment and color-code anatomy in the scanning field. By eliminating need to search through photos, a tremendous amount of time is freed up to concentrate on patient and diagnosis. Similarly, manufacturers of 3D ultrasound devices are emphasizing faster frame rates, superior resolutions, and enhanced color, Doppler. By enabling medical practitioners to offer prompt and efficient therapies to their patients, these developments can decrease number of incorrect diagnoses. This is expected to propel market revenue growth to a greater extent<\/p>\n

Some factors restraining 3D Ultrasound market revenue growth include cavitation produced by ultrasound in tissues and lack of qualified professionals performing ultrasound. FDA advises avoiding ultrasound unless recommended by a doctor as a part of paternal care, as ultrasonography is a medical technology and should be used for medical purposes and under-qualified professionals. These challenges can be overcome with time through continuous development and innovation of new 3D imaging technology.<\/p>\n

Some Key Highlights from the Report<\/strong><\/p>\n

On 07 October 2021, Philips Healthcare (a division of Koninklijke Philips N.V.) launched Ultrasound Workspace at the American College of Cardiology’s Annual Scientific Session & Expo (ACC 2022). Philips Ultrasound Workspace is a vendor-neutral echocardiography image analysis and reporting solution with remote browser access. Clinicians may now take advantage of integrated diagnostic workflows from ultrasound exam room to reporting room and beyond,<\/p>\n

The general imaging segment is expected to account for revenue largest share over the forecast period due to higher precision and sensitivity. Since real-time 3D ultrasound offers interactive feedback to assist doctors in obtaining high-quality images, as well as timely spatial information of scanned area, it is essential for intraoperative ultrasound examinations and has drawn a lot of interest in medical research.<\/p>\n

Browse Detailed Summary of Research Report with TOC@ https:\/\/www.emergenresearch.com\/industry-report\/3d-ultrasound-market<\/a><\/strong><\/p>\n

The cart-based devices segment accounted for largest revenue share in 2021. Point-of-Care Ultrasound (POCUS) scanners that are cart-based have started to gain popularity. These scanners were developed with POCUS user in mind, fusing best attributes of portable and conventional devices.<\/p>\n

The hospitals segment is expected to account for largest revenue share over the forecast period. Government spending on modernization of healthcare facility is rising and rapidly developing technology have led to the creation of compact, sophisticated 3D ultrasound devices, which are being quickly adopted in hospitals and diagnostic institutions. This is expected to drive revenue growth of the market.<\/p>\n

The North America market is expected to account for largest revenue share over the forecast period due to rising initiatives to adopt radiation-free devices for imaging and increasing popularity of 3D imaging technology. In addition, presence of major companies in this region is expected to drive market revenue growth<\/p>\n

Emergen Research has segmented the global 3D ultrasound market based on application, portability, end use, and region:<\/p>\n

Application Outlook (Revenue, USD Billion, 2019–2030)<\/strong><\/p>\n

General Imaging<\/p>\n

Cardiovascular<\/p>\n

Pain Management Applications<\/p>\n

POC<\/p>\n

Portability Outlook (Revenue, USD Billion, 2019–2030)<\/strong><\/p>\n

Cart-Based Devices<\/p>\n

Table-Top Devices<\/p>\n

End Use Outlook (Revenue, USD Billion, 2019–2030)<\/strong><\/p>\n

Hospitals<\/p>\n

Maternity Centers<\/p>\n

Ambulatory Care Centers<\/p>\n

Others<\/p>\n

To Get Moment Access, Buy Report Here @<\/strong> https:\/\/www.emergenresearch.com\/select-license\/1240<\/a><\/strong><\/p>\n

Regional Outlook (Revenue, USD Billion, 2019–2030)<\/strong><\/p>\n

North America<\/p>\n

U.S.<\/p>\n

Canada<\/p>\n

Mexico<\/p>\n

Europe<\/p>\n

Germany<\/p>\n

UK<\/p>\n

France<\/p>\n

Spain<\/p>\n

BENELUX<\/p>\n

Rest of Europe<\/p>\n

Asia Pacific<\/p>\n

China<\/p>\n

India<\/p>\n

Japan<\/p>\n

South Korea<\/p>\n

Rest of APAC<\/p>\n

Latin America<\/p>\n

Brazil<\/p>\n

Rest of LATAM<\/p>\n

Middle East & Africa<\/p>\n

Saudi Arabia<\/p>\n

UAE<\/p>\n

Israel<\/p>\n

Rest of Middle East & Africa<\/p>\n

The report addresses the following key points:<\/strong><\/p>\n

The report estimates the expected market size from 2021-2030<\/p>\n

The report provides a forecast of market drivers, restraints, and future opportunities for the 3D Ultrasound market<\/p>\n

The report further analyses the changing market dynamics<\/p>\n

Regional analysis and segmentation of the market with analysis of the regions and segments expected to dominate the market growth<\/p>\n

Extensive competitive landscape mapping with profiles of the key competitors<\/p>\n

In-depth analysis of business strategies and collaborations such as mergers and acquisitions adopted by the key companies<\/p>\n

Revenue forecast, country scope, application insights, and product insights<\/p>\n

Request customization of the report @ https:\/\/www.emergenresearch.com\/request-for-customization\/1240<\/a><\/strong><\/p>\n

Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.<\/p>\n

About Emergen Research<\/strong> <\/strong><\/p>\n

At Emergen Research, we believe in advancing with technology. We are a growing Marketresearch and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Emergen Research<\/a>
Contact Person:<\/strong> Eric Lee
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 (604) 757-9756
Address:<\/strong>14671 110 Avenue Surrey, British Columbia, V3R2A9
City:<\/strong> Surrey
State:<\/strong> British Columbia
Country:<\/strong> Canada
Website:<\/strong> https:\/\/www.emergenresearch.com\/industry-report\/3d-ultrasound-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

3D Ultrasound Market | Emergen Research Rapid technological advancements made in 3D imaging and rapidly shifting preference for Minimally Invasive Procedures (MIP) are driving market revenue growth The global 3D Ultrasound Market size was USD 3.28 Billion in 2021 and register a … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,412,406,404],"tags":[],"class_list":["post-610199","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-News-Current-Affairs","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/610199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=610199"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/610199\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=610199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=610199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=610199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}